Chronic obstructive pulmonary disease(COPD) poses a serious threat to human health, making it one of the major global public health burdens. In 2023, an expert consensus group was established to address key clinical questions in the integrated Chinese and western medicine management of COPD. Based on authoritative domestic and international guidelines and adapted to China's national conditions, the Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) was developed and published. To provide more scientific and practical guidance, a guideline development working group was formed as a project of the China Association of Chinese Medicine, with funding from multiple projects. The group integrated evidence-based medicine with expert experience and clinical realities, conducted systematic evidence retrieval and evidence grading, and ultimately developed the Guidelines for Integrated Traditional Chinese and Western Medicine in the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2025 Edition). This guideline introduces the selection of screening tools for COPD at primary healthcare institutions. Focusing on integrative strategies for prevention and treatment of COPD, this guideline addresses 8 core clinical questions and provides specific recommendations on various interventions, including population screening, oral Chinese medicine, external therapies, and traditional Chinese exercises. This guideline emphasizes the organic integration of Chinese and western medicine in the diagnosis and treatment of COPD, with a focus on individualized therapy, aiming to further enhance the comprehensive diagnosis, treatment, and management of COPD in China.

慢性阻塞性肺疾病（以下简称慢阻肺病）严重危害人类健康，是全球主要公共卫生负担之一。2023年，成立共识专家组，围绕慢阻肺病中西医结合的临床关键问题，基于国内外权威指南，结合中国国情，制订并发布了《慢性阻塞性肺疾病中西医结合管理专家共识》。为提供更科学、实用的指导性意见，由多个项目资助，在中华中医药学会立项，成立指南制订工作组，遵循循证证据与专家经验、临床实际情况相结合原则，开展系统的证据检索及证据等级评价，最终形成《慢性阻塞性肺疾病中西医结合诊疗指南（2025版）》。本指南介绍了基层医疗卫生机构慢阻肺病筛查工具的选择，聚焦中西医结合防治策略，围绕8个关键临床问题，就人群筛查、中医药内服、外治及传统功法等干预措施提出了具体推荐意见。本指南强调慢阻肺病中西医诊疗的有机结合，注重个体化治疗，以期进一步提升我国慢阻肺病的中西医结合综合诊治与管理水平。